Phenominer Database Results (9 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Clinical Measurement Notes Record ID Study ID
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (1 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 90.8 % 12.7 in vivo caliper method 0.0 0 Experiment 1 109482 3146
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (0.5 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 63.6 % 31.2 in vivo caliper method 0.0 0 Experiment 2 109491 3146
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (2 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 78.5 % 16.7 in vivo caliper method 0.0 0 Experiment 1 109483 3146
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (0.5 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 66.7 % 25.4 in vivo caliper method 0.0 0 Experiment 2 109488 3146
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (0.25 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 -2.5 % 15.9 in vivo caliper method 0.0 0 Experiment 2 109490 3146
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (1 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 100.0 % 0.0 in vivo caliper method 0.0 0 Experiment 1 109481 3146
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (0.25 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 29.3 % 23.3 in vivo caliper method 0.0 0 Experiment 2 109487 3146
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (1 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 95.8 % 9.4 in vivo caliper method 0.0 0 Experiment 2 109492 3146
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (1 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 89.8 % 14.0 in vivo caliper method 0.0 0 Experiment 2 109489 3146